Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14826 - 14844 of 14844 in total
AR-9281 inhibits soluble epoxide hydrolase.
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
ETC-1001 is Pfizer’s lead oral small molecule product candidate which is intended to be a chronic treatment for individuals with lipid disorders.
Investigational
AEOL 10150 is developed by Aeolus as a therapeutic agents based on its proprietary small molecule catalytic antioxidants.
Investigational
ING-1 is a high-affinity, human engineered trade mark monoclonal antibody that recognizes a 40 kilodalton epithelial cell adhesion molecule (EpCAM) glycoprotein that is expressed in high levels on most adenocarcinomas. It is an attractive target for immunotherapy.
Investigational
Benzoctamine is a drug with two main uses. It can be used as a sedative which does not depress the respiratory system, but rather stimulates it. It can also be used as an anxiolytic with the same efficacy as chlordiazepoxide for treating anxiety neurosis.
Experimental
Investigational
Alamifovir is an antiviral agent specific for HBV.
Investigational
Investigational
Investigational
PSN357 is a glycogen phosphorylase inhibitor (GPI), which is designed to rapidly lower blood glucose levels by preventing glycogen breakdown to glucose in the liver.
Investigational
Investigational
Investigational
Displaying drugs 14826 - 14844 of 14844 in total